In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease
2019 · Proceedings of the National Academy of Sciences · 143 citations
https://doi.org/10.1073/pnas.1815354116
S
Sumita Mishra
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
1.6K
Citations
19
h-index
25
i10-index
Sumita Mishra is an academic researcher from Virginia Cooperative Extension. The author has contributed to research in topics: Glycosylation and Glycoproteins Research & Cardiovascular Function and Risk Factors & Mitochondrial Function and Pathology. The author has an h-index of 19, co-authored 42 publications.
ORCID: 0000-0002-6455-4075Papers by this author
worksInteraction of annexin A6 with alpha actinin in cardiomyocytes
2011 · BMC Cell Biology · 24 citations
https://doi.org/10.1186/1471-2121-12-7
Cardiac cGMP Regulation and Therapeutic Applications
2024 · Hypertension · 13 citations
https://doi.org/10.1161/hypertensionaha.124.21709
Transient receptor potential canonical type 6 (TRPC6) O-GlcNAcylation at Threonine-221 plays potent role in channel regulation
2023 · iScience · 2 citations
https://doi.org/10.1016/j.isci.2023.106294
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat